PrimeRFP SCOUT · Federal Contract Profile

Collaborative Drug Discovery (KC1DAXHM8424)Federal contracts · 1 recompete

Collaborative Drug Discovery holds $2.2M in federal volume across 5 award actions, with 98% at Department of Health and Human Services (HHS). SCOUT tracks 1 incumbent recompete — an estimated $525K returning to market over the next 24 months (Low exposure). Primary work: Custom Computer Programming; Other Computer Related Services (100% prime). Obligations are roughly flat year over year.

$2.2M
Federal Volume
1
Recompetes (24mo)
HHS
Top Agency · 98% firm-wide
5
Award Actions

Choose one — this changes what we ask next

Score my firm against Collaborative Drug Discovery

Email me when a Collaborative Drug Discovery recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026

Why are you looking at Collaborative Drug Discovery?

Score my firm against Collaborative Drug Discovery

Email me when a Collaborative Drug Discovery recompete window opens.

What they do

Capability

Service lines

CUSTOM COMPUTER PROGRAMMING SERVICES · OTHER COMPUTER RELATED SERVICES

Work mix: 100% prime · 0% sub · primary NAICS 541511 / PSC 7A21 IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE)

Where they win

2 agencies
% of firm-wide obligated ($2.2M) · all agencies

Recompete exposure: Low · 1 in 24mo

Collaborative Drug Discovery has an estimated $525K in contracts returning to market over the next 24 months.

Recompete exposure & trajectory

Recompete exposure

Low

Collaborative Drug Discovery has an estimated $525K in contracts returning to market over the next 24 months.

Trajectory
Steady-3% YoYFY2025 vs FY2024
'24
'25
SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…
Gwyne Taylor, Tailored Global
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Collaborative Drug Discovery hold?

Collaborative Drug Discovery (UEI KC1DAXHM8424) shows $2.2M across 5 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Collaborative Drug Discovery have?

Collaborative Drug Discovery shows $2.2M across 5 award actions. SCOUT tracks 1 incumbent recompetes ($525K) returning to market in the next 24 months.

Which agencies does Collaborative Drug Discovery work with?

Collaborative Drug Discovery’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (98%), Department of Defense (DOD) (2%).

What is the UEI for Collaborative Drug Discovery?

The Unique Entity ID (UEI) for Collaborative Drug Discovery is KC1DAXHM8424.

Does Collaborative Drug Discovery have contracts coming up for recompete?

Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/collaborative-drug-discovery-inc